Provided by Tiger Fintech (Singapore) Pte. Ltd.

Applied DNA Sciences

0.7999
-0.0301-3.63%
Volume:364.37K
Turnover:293.72K
Market Cap:5.20M
PE:-0.01
High:0.8350
Open:0.8300
Low:0.7904
Close:0.8300
Loading ...

Applied DNA Sciences Inc expected to post a loss of $3.00 a share - Earnings Preview

Reuters
·
10 May

Applied DNA Sciences Inc expected to post a loss of $3.00 a share - Earnings Preview

Reuters
·
07 May

Applied DNA’s LineaRx ‘ready to support’ reshoring of drug development

TIPRANKS
·
21 Apr

Applied DNA Sciences Regains Nasdaq Compliance on Minimum Bid Price Rule

MT Newswires Live
·
08 Apr

Applied DNA regains compliance with Nasdaq minimum bid price rule

TIPRANKS
·
08 Apr

Applied DNA Positions TR8 PGx Testing Service as Pre-Emptive Testing for Safety of Fluoropyrimidine-Based Cancer Therapeutics Following Publication of Food and Drug Administration Safety Announcement

ACCESS Newswire
·
01 Apr

Applied DNA Seeks New York Approval for H5 Bird Flu Test

MT Newswires Live
·
26 Mar

Applied DNA Submits Validation Package to New York State Department of Health for H5 Bird Flu/Pan-Influenza A Laboratory-Developed Test

ACCESS Newswire
·
26 Mar

Analysts Offer Insights on Healthcare Companies: Anavex Life Sciences (AVXL) and Applied DNA Sciences (APDN)

TIPRANKS
·
28 Feb

Applied DNA Sciences Inc (APDN) Q1 2025 Earnings Call Highlights: Strategic Restructuring and ...

GuruFocus.com
·
14 Feb

Applied DNA Sciences (APDN) Reports Q1 Loss, Tops Revenue Estimates

Zacks
·
14 Feb

Applied DNA Sciences Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
14 Feb

Applied DNA Sciences: Fiscal Q1 Earnings Snapshot

Associated Press Finance
·
14 Feb

Applied DNA Sciences Q1 EPS $(0.56) Misses $(0.28) Estimate, Sales $1.20M Beat $1.10M Estimate

Benzinga
·
14 Feb

Applied DNA to Report First Quarter Fiscal 2025 Financial Results After Market Close on Thursday, February 13, 2025

ACCESS Newswire
·
13 Feb